http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2002500669-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02P20-55 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H17-08 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H17-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-70 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7048 |
| filingDate | 1998-05-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2002-01-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-2002500669-A |
| titleOfInvention | Polycyclic erythromycin derivatives |
| abstract | (57) Abstract: Formula (I), (II), (III), (IV), (V), (VI), (VII), (VIII), (IX), (X), or (XI) A) a novel polycyclic erythromycin compound having bacterial activity, and pharmaceutically acceptable salts and esters thereof, wherein a therapeutically effective amount of a compound of the present invention is combined with a pharmaceutically acceptable carrier. And a method of treating a bacterial infection comprising administering to a mammal a pharmaceutical composition comprising a therapeutically effective amount of a compound of formula (I). |
| priorityDate | 1997-05-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 310.